Form 8-K - Current report:
SEC Accession No. 0001213900-15-008841
Filing Date
2015-11-18
Accepted
2015-11-17 17:48:44
Documents
3
Period of Report
2015-11-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k111715_actiniumpharma.htm 8-K 14902
2 PRESS RELEASE OF ACTINIUM PHARMACEUTICALS, INC. f8k111715ex99i_actinium.htm EX-99.1 13651
3 GRAPHIC ex99i_01.jpg GRAPHIC 17250
  Complete submission text file 0001213900-15-008841.txt   53624
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 151239128
SIC: 2834 Pharmaceutical Preparations